References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Rynn et al., 2008",327,duloxetine: 60-120 mg/day,Caucasian,61.3,22.6,42.2,44.6,Eli Lilly and Company; Boehringer Ingelheim,10,dsm-iv
"Rynn et al., 2008",327,placebo,Caucasian,62.3,23.5,41.0,31.4,Eli Lilly and Company; Boehringer Ingelheim,10,dsm-iv
